Evaluate the Efficacy, Safety and Tolerability of TSUPPORT for Adults With Tourette Syndrome
Clinical trial NCT05183594 · UNKNOWN
Trial details
- NCT number
- NCT05183594
- Sponsor
- Tasly Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2024-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.